The guidance encourages the use of Bayesian statistics in drug trials. Instead of starting from scratch and only adding new ...

The proposed recommendations are intended to safely expedite approvals of promising therapies for multiple myeloma, but one expert is skeptical about the likelihood of industry compliance.

Elizabeth Troutman Mitchell is the White House Correspondent for "The Daily Signal." Send her an email. The Food and Drug Administration will issue guidelines requiring clinical trials prior to the ...

The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.

Licensed scientific and clinical intelligence integrated into the 3RnD platform to support AI-Driven Discovery and ...

The FDA has stopped new clinical trials that export American citizens’ living cells from the U.S. to “China and other hostile countries for genetic engineering and subsequent infusion” back into ...

Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...

A research team led by the Department of Medicine, under the School of Clinical Medicine, LKS Faculty of Medicine of the ...

BridgeBio Pharma Inc. BBIO stock is surging on Thursday and nearing the upper end of its 52-week range of $28.33-$84.94, according to Benzinga Pro data. The biopharmaceutical company focused on ...